Pascal's wager: Combining continuous glucose monitoring and continuous subcutaneous insulin infusion

Diabetes Technology and Therapeutics

Volumn 12, Issue SUPPL. 1, 2010, Pages

  Kerr, David ^a   Olateju, Tolu ^a  

^a BOURNEMOUTH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUOUS INFUSION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIET THERAPY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; LIFESTYLE MODIFICATION; LONG TERM CARE; PATIENT ASSESSMENT; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; SELF MONITORING; TREATMENT INDICATION;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MONITORING, AMBULATORY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TECHNOLOGY;

EID: 77956147520     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0017     Document Type: Review

References (46)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
2. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S; Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group: Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 2003;348:2294-2303.
3. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
4. McCrimmon RJ, Frier BM: Hypoglycaemia, the most feared complication of insulin therapy. Diabetes Metab 1994;20: 503-512.
5. Pickup JC, Kidd J, Burmiston S, Yemane M: Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 2006;22:232-237.
6. Owens D, Barnett A, Pickup J, Kerr D, Bushby P, Hicks D, Gadsby R, Frier B: Blood glucose self-monitoring in type 1 and type 2 diabetes: reaching a multidisciplinary consensus. Diabetes Primary Care 2004;6:8-16.
7. Klonoff DC, Bergenstal R, Blonde L, Boren SA, Church TS, Gaffaney J, Jovanovic L, Kendall DM, Kollman C, Kovatchev BP, Leippert C, Owens DR, Polonsky WH, Reach G, Renard E, Riddell MC, Rubin RR, Schnell O, Siminiero LM, Vigersky RA, Wilson DM, Wollitzer AO: Consensus report of the coalition for clinical research-self monitoring of blood glucose. J Diabetes Sci Technol 2008;2:1030-1053.
8. Coster S, Guilford MC, Seed PT, Powrie JK, Swaminathan R: Self-monitoring in Type 2 diabetes: a meta-analysis. Diabet Med 2000;17:755-761.
9. Bode BW, Sabbah H, Davidson PC: What's ahead in glucose monitoring? New techniques hold promise for improved ease and accuracy. Postgrad Med 2001;109:41-44, 47-49.
10. Ginsburg BH: An overview of minimally invasive technologies. Clin Chem 1992;38:1596-1600. Erratum in: Clin Chem 1992;38:2360.
11. Boland EA, Tamborlane WV: Continuous glucose monitoring in youth with type 2 diabetes: overcoming barriers to successful treatment. Diabetes Technol Ther 2000;2(Suppl 1):S53-S59.
12. Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV: Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care 2000;23:477-483.
13. Haller MJ, Stalvey MS, Silverstein JH: Predictors of control of diabetes: monitoring may be the key. J Pediatr 2004;144:660-661.
14. Reach G: Continuous glucose monitoring and diabetes health outcomes: a critical appraisal. Diabetes Technol Ther 2008;10:69-80.
15. Skeie S, Kristensen GB, Carlsen S, Sandberg S: Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C. J Diabetes Sci Technol 2009;3:83-88.
16. Cheyne EH, Cavan DA, Kerr D: Performance of a continuous glucose monitoring system during controlled hypogly-caemia in healthy volunteers. Diabetes Technol Ther 2002;4: 607-613.
17. Chetty VT, Almulla A, Odueyungbo A, Thabane L: The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1C) levels in type 1 diabetic patients: a systematic review. Diabetes Res Clin Pract 2008;81:79-84.
18. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, Fowler D, Campbell P, Temple RC: Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008;337:a1680. doi: 10. 1136/bmj. a1680.
19. Cooke D, Hurel SJ, Casbard A, Steed L, Wlaker S, Meredith S, Nunn AJ, Manca A, Sculpher M, Barnard M, Kerr D, Weaver JU, Alquist J, Newman SP: Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin-treated diabetes (MITRE Study). Diabet Med 2009;26:540-547.
20. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50.
21. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649.
22. Bailey TS, Zisser HC, Garg SK: Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther 2007;9:203-210.
23. Garg SK, Kelly WC, Voelmle MK, Ritchie PJ, Gottlieb PA, McFann KK, Ellis SL: Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care 2007;30:3023-3025.
24. JDRF Continuous Glucose Monitoring Study Group, Tam-borlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
25. Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, Kerr D, Phillip M: Improved glycemic control in poorly controlled patients with type 1 diabetes using realtime continuous glucose monitoring. Diabetes Care 2006;29: 2730-2732.
26. Mastrototaro J, Shin J, Marcus A, Sulur G; STAR 1 Clinical Trial Investigators: The accuracy and efficacy of real-time continuous glucose monitoring sensors in patients with type 1 diabetes. Diabetes Technol Ther 2008;10:385-390.
27. Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wyaocki T, Beck R, Tamborlane W, Ruedy K; Diabetes Research in Children Network (DirecNet) Study Group: FreeStyle Navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group. Diabetes Care 2008;31:525-527.
28. Raccah D, Sulmont V, Reznick Y, Guerci B, Renard E, Ha-naire H, Jeandidier N, Nicolino M: Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the Re-alTrend study. Diabetes Care 2009;32:2245-2250.
29. Hirsch IB, Abelseth J, Bode BW, Fischer JS, Kaufman FR, Mastrototaro J, Parkin CG, Wolpert HA, Buckingham BA: Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 2008;10:377-383.
30. Diabetes Research in Children Network (DirectNet) Study Group, Buckingham B, Beck RW, Tamborlane WV, Xing D, Kollman C, Fiallo-Scharer R, Mauras N, Ruedy KJ, Tansey M, Weinzimer SA, Wysocki T: Continuous glucose monitoring with type 1 diabetes. J Pediatr 2007;151:388-393.
31. Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, Wysocki T, Weinzimer S, Kollman C, Ruedy K, Xing D: A randomized multicenter trial comparing the Glucowatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005;28: 1101-1106.
32. Garg SK, Schwartz S, Edelman SV: Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004; 27:734-738.
33. Peyrot M, Rubin RR: Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system. Diabetes Technol Ther 2009;11:57-62.
34. JDRF Continuous Glucose Monitoring Group, Bode B, Beck RW, Xing D, Gilliam L, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Tamborlane WV, Weinzimer S, Wolpert H: Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009;32:2047-2049.
35. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Koll-man C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV: Factors predictive of use and benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009;32:1947-1953.
36. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383.
37. www.diabetesccre. unimelb. edu. au (accessed December 12, 2009).
38. Diabetes UK 2008: Continuous Glucose Monitoring-Posi-tion Statement. www.diabetes.org. uk/cgm (accessed March 15, 2010).
39. American Diabetes Association: Summary of revisions for the 2009 clinical practice recommendations. Diabetes Care 2009;32(Suppl 1):S3-S5.
40. Hvorka R: Continuous glucose monitoring and closed-loop systems. Diabet Med 2006;23:1-12.
41. Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F, Chase HP: Preventing hypogly-cemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther 2009;11:93-97.
42. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939.
43. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB: Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-751.
44. Renard E: Closed-loop insulin delivery: is the holy grail near? Lancet 2010;375:702-703.
45. Kerr D, Partridge H: Numeracy and diabetes. The elephant in the room. Diabet Med (in press).
46. Shaughnessy A, Slawson D: What happened to valid POEMS? A survey of review articles on type 2 diabetes. BMJ 2003;327:266.